Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada - A multicenter survey of 2001 patients

International Journal of Dermatology

Volumn 36, Issue 10, 1997, Pages 783-787

  Gupta, Aditya K ^a,e   Jain, Hem C ^b   Lynde, Charles W ^c   Watteel, Gena N ^a   Summerbell, Richard C ^d  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AWARENESS; CANADA; CLINICAL TRIAL; CONFERENCE PAPER; DERMATOLOGY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOLOGY; ONYCHOMYCOSIS; PREVALENCE; SKIN INFECTION; TOE;

EID: 0030725964     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1997.00349.x     Document Type: Conference Paper

References (18)

1. Pardo-Castello V, Pardo OA. Diseases of the Nails. Springfield, Illinois: Charles C Thomas, 1960.
2. Achten G, Wanet-Rouard J. Onychomycoses in the laboratory. Mykosen 1978; 21: 125-12.7.
3. Langer H. Epidemiologische and klinische Untersuchungen bei onychomykosen. Archiv fur klinische und experimentelle Dermatologie 1957; 204: 624.
4. Reynaers H. Coup d'oeil statistique sur 23,000 observations de dermatoses examinées en l'espace de 12 ans. Archives Belges de Dermatologie et de Syphiligraphie 1960; 16: 17-78.
5. Vanbreuseghem R. Prévalence des onychomycoses en Zaïre particulièrement chez les coupeurs de canne à sucre. Ami Soc Belg Med Trop 1977; 57: 7-15.
6. Walshe MM, English MP. Fungi in nails. Br J Dermatol 1966; 78: 198-207.
7. Seebacher C. Untersuchungen über die pilzflora kranker und gesunder Zehennägel. Mykosen 1968; n: 893.
8. Achten G, Wanet-Rouard J. Onychomycosis. Mycology, No. 5. Brussels: Cilag, Ltd, 1978.
9. Skin Conditions and Related Need for Medical Care Among Persons 1-74 Years, United States, 1971-1974. US Department of Health, Education and Welfare, Vital and Health Statistics, Series n, No. 212, November 1978.
10. Roberts DT. Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey. Er ] Dermatol, 1993; 126 (Suppl 39): 2.3-17.
11. Sais G, Jucglà A, Peyrï J. Prevalence of dermatophyte onychomycosis in Spain: a cross-sectional study. Br } Dermatol 1995; 132: 758-761.
12. z Heikkilä H, Stubb S. The prevalence of onychomycosis in Finland. Br J Dermatol 1995; 133: 699-703.
13. Charif MA, Elewski BE. Prevalence of onychomycosis in the United States: results of a population based survey. Abstract Form 17. In: International Summit on Cutaneous Antifungal Therapy Programme, May 16-18, 1996. Vancouver: 1996.
14. Buxton PK, Milne LJR, Prescott RJ, et al. The prevalence of dermatophyte infection in well-controlled diabetics and time response to Trichophyton antigen. Br ] Dermatol 1996; 134: 900-903.
15. Population Projections for Canada, Provinces and Territories 1993-2016. Ottawa: Statistics Canada, 1994.
16. demons KV, Schar G, Stover EP, étal. Dermatophytehormone relationships: characterization of progesteronebinding specificity and growth inhibition in the genera Trichophyton and Microsporttm. ] Clin Microbiol 1988; 2.6: 1110-10115.
17. Daniel CR. Nonfungal infections. In: Scher RK, Daniel CR, eds. Nails: Therapy, Diagnosis, Surgery. Toronto: W.B. Saunders Company, 1990: 120-116.
18. Greer DL. Evolving role of nondermatophytes in onychomycosis. Int J Dermatol 1995; 34: 521-514.